Recently, Shenzhen Carewell Electronics Co., Ltd., a subsidiary of Lepu Medical (300003. SZ), launched its new ECG tablets--Neo ECG T180 and Neo ECG S120. Supporting connection with AI-ECG Platform, Neo ECG tablet allows the hospitals and medical centers to achieve intelligence diagnosis. This marks Lepu's solid step towards AI-powered solutions.
What Is An AI-ECG Platform?
Independently developed by Lepu Medical, AI-ECG Platform is an assisted analysis and diagnosis systemof artificial intelligence (AI) electrocardiogram (ECG) . It provides an intelligent in-hospital solution to assist clinical decision-making.
Highlights of AI ECG Platform
The analysis results turn out to be highly accurate. Tested by 1,000,000 independent MIT test data, the average accuracy of AI-ECG platform reaches 95.2%.
Its high-speed feature makes it a time-saver. The AI-ECG Platform takes merely 1 second to rest ECG analysis automatically, which can reduce the overall time of clinical ECG analysis.
It enables comprehensive diagnosis. ThisAI ECG platform supports 16 types of cardiac malfunction classification and 104 types of ECG diagnostic classification.
Main Features of Neo ECG Tablets
• 7'' / 10.1'' high resolution color touch screen, easy to operate
• Base with build-in thermal printer and support external laser printer
• Support connection with AI-ECG PLATFORM in achieving intelligence diagnosis.
For more information on Lepu Medical Neo ECG Tablet, please visit: https://en.lepumedical.com/products/neo-ecg/
Email Us: